Expanded Use of Xolair to Treat Food Allergies Approved by the FDA
FRIDAY, Feb. 16, 2024 -- The U.S. Food and Drug Administration has expanded the use of the asthma drug Xolair (omalizumab) to help prevent anaphylactic reactions.Xolair is an injected drug and is not meant as a substitute for EpiPens or other...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Allergy | Allergy & Immunology | Anaphylactic Shock | Asthma | Food Allergy | Food and Drug Administration (FDA) | Pharmaceuticals | Xolair